EA200970923A1 - АНТИ-EpСАМ АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕ - Google Patents
АНТИ-EpСАМ АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕInfo
- Publication number
- EA200970923A1 EA200970923A1 EA200970923A EA200970923A EA200970923A1 EA 200970923 A1 EA200970923 A1 EA 200970923A1 EA 200970923 A EA200970923 A EA 200970923A EA 200970923 A EA200970923 A EA 200970923A EA 200970923 A1 EA200970923 A1 EA 200970923A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antibody
- epsam
- application
- therapeutic
- designated
- Prior art date
Links
- 241001529936 Murinae Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Abstract
Описывается анти-ЕрСАМ антитело, обозначенное как ST3232/10, мышиного происхождения, которое демонстрирует свойства, подходящие для терапевтического и диагностического применения. Указанное антитело демонстрирует высокую аффинность для нативного антигена и хорошую опухолевую специфичность.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07105628 | 2007-04-04 | ||
PCT/EP2008/053913 WO2008122551A2 (en) | 2007-04-04 | 2008-04-02 | Anti-epcam antibody and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200970923A1 true EA200970923A1 (ru) | 2010-04-30 |
EA023679B1 EA023679B1 (ru) | 2016-06-30 |
Family
ID=38458122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970923A EA023679B1 (ru) | 2007-04-04 | 2008-04-02 | АНТИ-EpCAM АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕ |
Country Status (21)
Country | Link |
---|---|
US (1) | US8318911B2 (ru) |
EP (1) | EP2142570B1 (ru) |
JP (1) | JP5631733B2 (ru) |
KR (1) | KR101683884B1 (ru) |
CN (1) | CN101970497B (ru) |
AT (1) | ATE512988T1 (ru) |
AU (1) | AU2008235566B2 (ru) |
BR (1) | BRPI0810096A8 (ru) |
CA (1) | CA2682296C (ru) |
CY (1) | CY1111819T1 (ru) |
DK (1) | DK2142570T3 (ru) |
EA (1) | EA023679B1 (ru) |
ES (1) | ES2367675T3 (ru) |
HR (1) | HRP20110620T1 (ru) |
IL (1) | IL201196A0 (ru) |
MX (1) | MX2009010444A (ru) |
PL (1) | PL2142570T3 (ru) |
PT (1) | PT2142570E (ru) |
RS (1) | RS52040B (ru) |
SI (1) | SI2142570T1 (ru) |
WO (1) | WO2008122551A2 (ru) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9169516B2 (en) | 2003-01-24 | 2015-10-27 | University Of Utah Research Foundation | Methods of predicting mortality risk by determining telomere length |
JP5840950B2 (ja) | 2008-12-22 | 2016-01-06 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | 単色マルチプレックス定量pcr |
GB0909904D0 (en) * | 2009-06-09 | 2009-07-22 | Affitech As | Product |
CN103561771B (zh) | 2011-03-17 | 2019-01-04 | 伯明翰大学 | 重新定向的免疫治疗 |
CN107315086B (zh) * | 2011-06-29 | 2019-09-10 | 中央研究院 | 使用表面涂层对生物物质的捕获、纯化和释放 |
EP2819695B1 (en) * | 2012-03-02 | 2018-06-27 | Academia Sinica | ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF |
US9494500B2 (en) | 2012-10-29 | 2016-11-15 | Academia Sinica | Collection and concentration system for biologic substance of interest and use thereof |
JP6546158B2 (ja) | 2013-05-22 | 2019-07-17 | テロメア ダイアグノスティクス インコーポレイテッド | 短いテロメアの存在量の測定 |
EP3126814B1 (en) | 2014-04-01 | 2019-06-12 | Academia Sinica | Methods and systems for cancer diagnosis and prognosis |
EP2998026B1 (en) | 2014-08-26 | 2024-01-17 | Academia Sinica | Collector architecture layout design |
AU2015372584A1 (en) | 2014-12-30 | 2017-06-29 | Telomere Diagnostics, Inc. | Multiplex quantitative PCR |
EP3328897A1 (en) | 2015-07-31 | 2018-06-06 | Sutro Biopharma, Inc. | ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EPCAM ANTIBODIES |
US10107726B2 (en) | 2016-03-16 | 2018-10-23 | Cellmax, Ltd. | Collection of suspended cells using a transferable membrane |
WO2017173091A1 (en) * | 2016-03-30 | 2017-10-05 | Musc Foundation For Research Development | Methods for treatment and diagnosis of cancer by targeting glycoprotein a repetitions predominant (garp) and for providing effective immunotherapy alone or in combination |
AU2017301826A1 (en) | 2016-07-26 | 2019-03-14 | Tessa Therapeutics Ltd. | Chimeric antigen receptor |
WO2020018964A1 (en) | 2018-07-20 | 2020-01-23 | Fred Hutchinson Cancer Research Center | Compositions and methods for controlled expression of antigen-specific receptors |
JP2022514262A (ja) | 2018-12-17 | 2022-02-10 | レビトープ リミテッド | 双子型免疫細胞エンゲージャー |
WO2020216210A1 (zh) * | 2019-04-22 | 2020-10-29 | 江苏恒瑞医药股份有限公司 | 抗EpCAM抗体及其应用 |
US11851499B2 (en) | 2019-06-11 | 2023-12-26 | Bioatla, Inc. | Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof |
CN110950959B (zh) * | 2020-02-25 | 2020-07-03 | 和铂医药(上海)有限责任公司 | 靶向EpCAM的抗体及其制备和应用 |
CN112094350B (zh) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
US5525338A (en) | 1992-08-21 | 1996-06-11 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin conjugates |
IT1245748B (it) | 1990-12-21 | 1994-10-14 | Mini Ricerca Scient Tecnolog | Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego |
US5578287A (en) * | 1992-06-09 | 1996-11-26 | Neorx Corporation | Three-step pretargeting methods using improved biotin-active agent |
JP3427871B2 (ja) * | 1996-06-24 | 2003-07-22 | 戸田工業株式会社 | コバルト被着型針状磁性酸化鉄粒子粉末 |
ITRM20010079A1 (it) | 2001-02-16 | 2002-08-16 | Sigma Tau Ind Farmaceuti | Amminoderivati della biotina e loro coniugati con chelanti macrociclici. |
US20050180979A1 (en) * | 2004-02-13 | 2005-08-18 | Micromet Ag | Anti-EpCAM immunoglobulins |
US7435804B2 (en) * | 2004-10-19 | 2008-10-14 | Phage Biotechnology, Inc. | Method for obtaining single chain antibodies to human interferon α2b |
-
2008
- 2008-04-02 ES ES08759374T patent/ES2367675T3/es active Active
- 2008-04-02 PT PT08759374T patent/PT2142570E/pt unknown
- 2008-04-02 AT AT08759374T patent/ATE512988T1/de active
- 2008-04-02 EP EP08759374A patent/EP2142570B1/en active Active
- 2008-04-02 RS RS20110388A patent/RS52040B/en unknown
- 2008-04-02 US US12/594,559 patent/US8318911B2/en active Active
- 2008-04-02 PL PL08759374T patent/PL2142570T3/pl unknown
- 2008-04-02 JP JP2010501503A patent/JP5631733B2/ja not_active Expired - Fee Related
- 2008-04-02 SI SI200830364T patent/SI2142570T1/sl unknown
- 2008-04-02 BR BRPI0810096A patent/BRPI0810096A8/pt not_active Application Discontinuation
- 2008-04-02 KR KR1020097023099A patent/KR101683884B1/ko active IP Right Grant
- 2008-04-02 EA EA200970923A patent/EA023679B1/ru not_active IP Right Cessation
- 2008-04-02 CN CN200880015767.4A patent/CN101970497B/zh not_active Expired - Fee Related
- 2008-04-02 MX MX2009010444A patent/MX2009010444A/es active IP Right Grant
- 2008-04-02 DK DK08759374.5T patent/DK2142570T3/da active
- 2008-04-02 AU AU2008235566A patent/AU2008235566B2/en not_active Ceased
- 2008-04-02 CA CA2682296A patent/CA2682296C/en not_active Expired - Fee Related
- 2008-04-02 WO PCT/EP2008/053913 patent/WO2008122551A2/en active Application Filing
-
2009
- 2009-09-24 IL IL201196A patent/IL201196A0/en active IP Right Grant
-
2011
- 2011-08-24 HR HR20110620T patent/HRP20110620T1/hr unknown
- 2011-09-06 CY CY20111100854T patent/CY1111819T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US8318911B2 (en) | 2012-11-27 |
AU2008235566A1 (en) | 2008-10-16 |
SI2142570T1 (sl) | 2012-01-31 |
ATE512988T1 (de) | 2011-07-15 |
MX2009010444A (es) | 2009-10-20 |
JP5631733B2 (ja) | 2014-11-26 |
RS52040B (en) | 2012-04-30 |
CY1111819T1 (el) | 2015-10-07 |
EP2142570A2 (en) | 2010-01-13 |
KR101683884B1 (ko) | 2016-12-07 |
CN101970497B (zh) | 2017-05-10 |
US20100092491A1 (en) | 2010-04-15 |
CA2682296A1 (en) | 2008-10-16 |
HRP20110620T1 (hr) | 2011-09-30 |
WO2008122551A3 (en) | 2008-12-04 |
BRPI0810096A8 (pt) | 2017-12-26 |
WO2008122551A2 (en) | 2008-10-16 |
CA2682296C (en) | 2017-02-28 |
ES2367675T3 (es) | 2011-11-07 |
CN101970497A (zh) | 2011-02-09 |
IL201196A0 (en) | 2010-05-17 |
EP2142570B1 (en) | 2011-06-15 |
PL2142570T3 (pl) | 2011-11-30 |
PT2142570E (pt) | 2011-09-13 |
JP2010523096A (ja) | 2010-07-15 |
EA023679B1 (ru) | 2016-06-30 |
BRPI0810096A2 (pt) | 2014-10-21 |
KR20100016237A (ko) | 2010-02-12 |
AU2008235566B2 (en) | 2013-06-06 |
DK2142570T3 (da) | 2011-10-03 |
WO2008122551A9 (en) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200970923A1 (ru) | АНТИ-EpСАМ АНТИТЕЛО И ЕГО ПРИМЕНЕНИЕ | |
CY1119454T1 (el) | Αντισωματα εναντι cd38 για τη θεραπεια του πολλαπλου μυελωματος | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
PH12020550741A1 (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
EA200800812A1 (ru) | Композиции антитела против cd3 | |
EA200900040A1 (ru) | Молекулы антител, которые связываются с человеческим il-17 | |
EA200970210A1 (ru) | Prlr-специфическое антитело и его применения | |
MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
EA201692127A1 (ru) | Антитела, связывающиеся с человеческим dec-205 | |
EA201171060A1 (ru) | Молекулы антител, обладающих специфичностью к человеческому ох40 | |
UA113712C2 (xx) | Антитіло до fap і способи його застосування | |
UA106194C2 (ru) | Диагностика и лечение рака с применением антитела к ereg | |
MA33757B1 (fr) | Protéines de liaison à l'antigène de l'il-23 humaine | |
EA200800953A1 (ru) | Человеческие моноклональные антитела к cd70 | |
EA200801174A1 (ru) | Антитела-миметики glp-2, полипептиды, композиции, способы и применения | |
BR112012007523A2 (pt) | moléculas de anticorpo anti-gcc e composições e métodos relacionados | |
NO20084546L (no) | Diagnostikk og behandlinger for tumorer | |
EA200801427A1 (ru) | Молекулы антитела со специфической активностью в отношении интерлейкина-6 (ил-6) человека | |
MX2021000392A (es) | Anticuerpos anti-mesotelina. | |
ECSP088241A (es) | Un conjugado citotóxico ca6 antígeno-específico y métodos para utilizar el mismo | |
EA202191175A1 (ru) | Сконструированные с цистеином конъюгаты антитело-лекарственное средство, содержащие пептидсодержащие линкеры | |
PH12013502194A1 (en) | Antibodies to egfl7 and methods for their use | |
EA201992316A1 (ru) | Композиции и способы для диагностики рака предстательной железы | |
EA202192418A1 (ru) | Способы лечения al-амилоидоза | |
MX2022002371A (es) | Un anticuerpo de dominio único para dirigirse al antígeno de membrana específico de la próstata (psma). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): TJ |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TM RU |